Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18576337 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  D2E7-Early AS
Condition: Ankylosing Spondylitis
Intervention: Drug: Adalimumab 40 mg sc every other week

Indicates status has not been verified in more than two years